Avocet Medical is focused to improved patient outcomes, reduced overall costs and expanded access to testing for those at risk of stroke. The firm developed, produced and sold professional point-of-care and home self-test diagnostic systems and solutions that advance the practice of anticoagulation therapy management. Avocet marketed the innovative "AvoSure" hand-held meter for monitoring oral anticoagulants (warfarin and Coumadin). The company received approval from the FDA and Medicare, and received several prestigious awards, including the best new research award from the American Association for Medical Instrumentation. In January 2002, Avocet was sold to Beckman-Coulter, who will continue the AvoSure system under the Beckman-Coulter brand name
